Non-toxigenic Vibrio cholerae – just another cause of vibriosis or a potential new pandemic?
Abstract
Although nontoxigenic Vibrio cholerae usually stands in the shadow of the two serogroups (O1 and O139) that cause pandemic cholera, its role in human pathology is increasingly recognized and described in the literature. The habitat of these pathogens is brackish seawater or even freshwater, and the infections caused by them include contact with these waters or consumption of seafood originating in this habitat, which is constantly expanding because of global warming. This habitat extension is a typical example of climate change's impact on infectious diseases. Although nontoxigenic Vibrio cholerae strains are rarely capable of producing the classical cholera toxin, they possess many other virulence factors, can secrete various other toxins, and thus produce illnesses that are sometimes even severe or life-threatening, more frequently in immunocompromised patients. Vibriosis may manifest as gastrointestinal illnesses, wounds, skin or subcutaneous tissue infections, or septicemia. To establish the correct etiological diagnosis for these infections, a high index of suspicion must be maintained, as the diagnostic techniques require targeted investigations and specific collection and transportation of the samples. Empiric treatment recommendations are available, but owing to the increasing resistance of this pathogen, susceptibility testing is needed for every diagnosed case. We intend to raise awareness regarding these infections, as they tend to be more frequent than they were in the past and to appear in areas where they had not been recognized before.
##plugins.themes.bootstrap3.article.details##
Vibrio cholerae, cholera, diarrhea, seafood, toxin, zoonosis
2. Baker-Austin C, Trinanes J, Gonzalez-Escalona N, Martinez-Urtaza J. Non-Cholera Vibrios: The Microbial Barometer of Climate Change. Trends Microbiol. 2017 Jan;25(1):76-84. doi: 10.1016/j.tim.2016.09.008. PMID: 27843109.
3. Cardoso MD, Lemos LS, Roges EM, et al. A comprehensive survey of Aeromonas sp. and Vibrio sp. in seabirds from southeastern Brazil: outcomes for public health. J Appl Microbiol. 2018 May;124(5):1283-1293. doi: 10.1111/jam.13705. PMID: 29356247.
4. Anderson AM, Varkey JB, Petti CA, et al. Non-O1 Vibrio cholerae septicemia: case report, discussion of literature, and relevance to bioterrorism. Diagn Microbiol Infect Dis. 2004 Aug;49(4):295-7. doi: 10.1016/j.diagmicrobio.2004.04.016. PMID: 15313536.
5. Suankratay C, Phantumchinda K, Tachawiboonsak W, Wilde H. Non serogroup O:1 Vibrio cholerae bacteremia and cerebritis. Clin Infect Dis. 2001 Apr 1;32(7):E117-9. doi: 10.1086/319596. PMID: 11264049.
6. Montero DA, Vidal RM, Velasco J, et al. Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development. Front Med (Lausanne). 2023 May 5;10:1155751. doi: 10.3389/fmed.2023.1155751. PMID: 37215733; PMCID: PMC10196187.
7. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet. 2012 Jun 30;379(9835):2466-2476. doi: 10.1016/S0140-6736(12)60436-X. PMID: 22748592; PMCID: PMC3761070.
8. Chowdhury F, Ross AG, Islam MT, McMillan NAJ, Qadri F. Diagnosis, Management, and Future Control of Cholera. Clin Microbiol Rev. 2022 Sep 21;35(3):e0021121. doi: 10.1128/cmr.00211-21. PMID: 35726607; PMCID: PMC9491185.
9. Kaper JB, Morris JG Jr, Levine MM. Cholera. Clin Microbiol Rev. 1995 Jan;8(1):48-86. doi: 10.1128/CMR.8.1.48. Erratum in: Clin Microbiol Rev 1995 Apr;8(2):316. PMID: 7704895; PMCID: PMC172849.
10. Heidelberg JF, Eisen JA, Nelson WC, et al. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature. 2000 Aug 3;406(6795):477-83. doi: 10.1038/35020000. PMID: 10952301; PMCID: PMC8288016.
11. Egan ES, Waldor MK. Distinct replication requirements for the two Vibrio cholerae chromosomes. Cell. 2003 Aug 22;114(4):521-30. doi: 10.1016/s0092-8674(03)00611-1. PMID: 12941279.
12. Nair GB, Faruque SM, Bhuiyan NA, et al. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol. 2002 Sep;40(9):3296-9. doi: 10.1128/JCM.40.9.3296-3299.2002. PMID: 12202569; PMCID: PMC130785.
13. Bundi M, Shah MM, Odoyo E, et al. Characterization of Vibrio cholerae O1 isolates responsible for cholera outbreaks in Kenya between 1975 and 2017. Microbiol Immunol. 2019 Sep;63(9):350-358. doi: 10.1111/1348-0421.12731. PMID: 31407393.
14. Dutta D, Chowdhury G, Pazhani GP, et al. Vibrio cholerae non-O1, non-O139 serogroups and cholera-like diarrhea, Kolkata, India. Emerg Infect Dis. 2013 Mar;19(3):464-7. doi: 10.3201/eid1903.121156. PMID: 23622872; PMCID: PMC3647666.
15. Hao T, Zheng W, Wu Y, et al. Population genomics implies potential public health risk of two non-toxigenic Vibrio cholerae lineages. Infect Genet Evol. 2023 Aug;112:105441. doi: 10.1016/j.meegid.2023.105441. PMID: 37146742.
16. Domman D, Quilici ML, Dorman MJ, et al. Integrated view of Vibrio cholerae in the Americas. Science. 2017 Nov 10;358(6364):789-793. doi: 10.1126/science.aao2136. PMID: 29123068.
17. Mutreja A, Kim DW, Thomson NR, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011 Aug 24;477(7365):462-5. doi: 10.1038/nature10392. PMID: 21866102; PMCID: PMC3736323.
18. Wang H, Yang C, Sun Z, et al. Genomic epidemiology of Vibrio cholerae reveals the regional and global spread of two epidemic non-toxigenic lineages. PLoS Negl Trop Dis. 2020 Feb 18;14(2):e0008046. doi: 10.1371/journal.pntd.0008046. PMID: 32069325; PMCID: PMC7048298.
19. Chin CS, Sorenson J, Harris JB, et al. The origin of the Haitian cholera outbreak strain. N Engl J Med. 2011 Jan 6;364(1):33-42. doi: 10.1056/NEJMoa1012928. PMID: 21142692; PMCID: PMC3030187.
20. Ramamurthy T, Nandy RK, Mukhopadhyay AK, et al. Virulence Regulation and Innate Host Response in the Pathogenicity of Vibrio cholerae. Front Cell Infect Microbiol. 2020 Sep 30;10:572096. doi: 10.3389/fcimb.2020.572096. PMID: 33102256; PMCID: PMC7554612.
21. Pérez-Reytor D, Jaña V, Pavez L, Navarrete P, García K. Accessory Toxins of Vibrio Pathogens and Their Role in Epithelial Disruption During Infection. Front Microbiol. 2018 Sep 20;9:2248. doi: 10.3389/fmicb.2018.02248. PMID: 30294318; PMCID: PMC6158335.
22. Uzzau S, Lu R, Wang W, Fiore C, Fasano A. Purification and preliminary characterization of the zonula occludens toxin receptor from human (CaCo2) and murine (IEC6) intestinal cell lines. FEMS Microbiol Lett. 2001 Jan 1;194(1):1-5. doi: 10.1111/j.1574-6968.2001.tb09437.x. PMID: 11150657.
23. Ogura K, Terasaki Y, Miyoshi-Akiyama T, et al. Vibrio cholerae Cholix Toxin-Induced HepG2 Cell Death is Enhanced by Tumor Necrosis Factor-Alpha Through ROS and Intracellular Signal-Regulated Kinases. Toxicol Sci. 2017 Apr 1;156(2):455-468. doi: 10.1093/toxsci/kfx009. PMID: 28087840; PMCID: PMC5837519.
24. Satchell KJF. Multifunctional-autoprocessing repeats-in-toxin (MARTX) Toxins of Vibrios. Microbiol Spectr. 2015 Jun;3(3):10.1128/microbiolspec.VE-0002-2014. doi: 10.1128/microbiolspec.VE-0002-2014. PMID: 26185092; PMCID: PMC4509488.
25. Silva AJ, Benitez JA. Transcriptional regulation of Vibrio cholerae hemagglutinin/protease by the cyclic AMP receptor protein and RpoS. J Bacteriol. 2004 Oct;186(19):6374-82. doi: 10.1128/JB.186.19.6374-6382.2004. PMID: 15375117; PMCID: PMC516606.
26. Rai AK, Chattopadhyay K. Revisiting the membrane interaction mechanism of a membrane-damaging β-barrel pore-forming toxin Vibrio cholerae cytolysin. Mol Microbiol. 2015 Sep;97(6):1051-62. doi: 10.1111/mmi.13084. PMID: 26059432.
27. Merrell DS, Bailey C, Kaper JB, Camilli A. The ToxR-mediated organic acid tolerance response of Vibrio cholerae requires OmpU. J Bacteriol. 2001 May;183(9):2746-54. doi: 10.1128/JB.183.9.2746-2754.2001. Erratum in: J Bacteriol 2001 Jul;183(13):4103. PMID: 11292792; PMCID: PMC99489.
28. Sack DA, Tacket CO, Cohen MB, et al. Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun. 1998 May;66(5):1968-72. doi: 10.1128/IAI.66.5.1968-1972.1998. PMID: 9573077; PMCID: PMC108151.
29. Simonet VC, Baslé A, Klose KE, Delcour AH. The Vibrio cholerae porins OmpU and OmpT have distinct channel properties. J Biol Chem. 2003 May 9;278(19):17539-45. doi: 10.1074/jbc.M301202200. PMID: 12606562.
30. Butler SM, Camilli A. Going against the grain: chemotaxis and infection in Vibrio cholerae. Nat Rev Microbiol. 2005 Aug;3(8):611-20. doi: 10.1038/nrmicro1207. PMID: 16012515; PMCID: PMC2799996.
31. Bachmann V, Kostiuk B, Unterweger D, et al. Bile Salts Modulate the Mucin-Activated Type VI Secretion System of Pandemic Vibrio cholerae. PLoS Negl Trop Dis. 2015 Aug 28;9(8):e0004031. doi: 10.1371/journal.pntd.0004031. PMID: 26317760; PMCID: PMC4552747.
32. Millet YA, Alvarez D, Ringgaard S, et al. Insights into Vibrio cholerae intestinal colonization from monitoring fluorescently labeled bacteria. PLoS Pathog. 2014 Oct 2;10(10):e1004405. doi: 10.1371/journal.ppat.1004405. PMID: 25275396; PMCID: PMC4183697.
33. George N, Fredrick F, Mohapatra A, et al. Non-O1, non-O139 Vibrio cholerae sepsis in a patient with nephrotic syndrome. Indian J Nephrol. 2013 Sep;23(5):378-80. doi: 10.4103/0971-4065.116329. PMID: 24049279; PMCID: PMC3764717.
34. Johnson JA, Panigrahi P, Morris JG Jr. Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun. 1992 Mar;60(3):864-9. doi: 10.1128/iai.60.3.864-869.1992. PMID: 1311706; PMCID: PMC257566.
35. Thompson FL, Iida T, Swings J. Biodiversity of vibrios. Microbiol Mol Biol Rev. 2004 Sep;68(3):403-31, table of contents. doi: 10.1128/MMBR.68.3.403-431.2004. PMID: 15353563; PMCID: PMC515257.
36. Singleton FL, Attwell R, Jangi S, Colwell RR. Effects of temperature and salinity on Vibrio cholerae growth. Appl Environ Microbiol. 1982 Nov;44(5):1047-58. doi: 10.1128/aem.44.5.1047-1058.1982. PMID: 6295276; PMCID: PMC242147.
37. Tall A, Hervio-Heath D, Teillon A, et al. Diversity of Vibrio spp. isolated at ambient environmental temperature in the Eastern English Channel as determined by pyrH sequencing. J Appl Microbiol. 2013 Jun;114(6):1713-24. doi: 10.1111/jam.12181. PMID: 23473469.
38. Johnston MD, Brown MH. An investigation into the changed physiological state of Vibrio bacteria as a survival mechanism in response to cold temperatures and studies on their sensitivity to heating and freezing. J Appl Microbiol. 2002;92(6):1066-77. doi: 10.1046/j.1365-2672.2002.01657.x. PMID: 12010547.
39. Fu S, Shen J, Liu Y, Chen K. A predictive model of Vibrio cholerae for combined temperature and organic nutrient in aquatic environments. J Appl Microbiol. 2013 Feb;114(2):574-85. doi: 10.1111/jam.12058. PMID: 23126672.
40. Louis VR, Russek-Cohen E, Choopun N, et al. Predictability of Vibrio cholerae in Chesapeake Bay. Appl Environ Microbiol. 2003 May;69(5):2773-85. doi: 10.1128/AEM.69.5.2773-2785.2003. PMID: 12732548; PMCID: PMC154498.
41. Sheikh HI, Najiah M, Fadhlina A, et al. Temperature upshift mostly but not always enhances the growth of vibrio species: a systematic review. Front. Marine Sci. 2022;9. doi: 10.3389/fmars.2022.959830
42. Zhou Y, Lee ZL, Zhu J. On or Off: Life-Changing Decisions Made by Vibrio cholerae Under Stress. Infect Microbes Dis. 2020 Oct 14;2(4):127-135. doi: 10.1097/IM9.0000000000000037. PMID: 38630076; PMCID: PMC7769058.
43. Huq A, West PA, Small EB, Huq MI, Colwell RR. Influence of water temperature, salinity, and pH on survival and growth of toxigenic Vibrio cholerae serovar 01 associated with live copepods in laboratory microcosms. Appl Environ Microbiol. 1984 Aug;48(2):420-4. doi: 10.1128/aem.48.2.420-424.1984. PMID: 6486784; PMCID: PMC241529.
44. Colwell RR, Kaper J, Joseph SW. Vibrio cholerae, Vibrio parahaemolyticus, and other vibrios: occurrence and distribution in Chesapeake Bay. Science. 1977 Oct 28;198(4315):394-6. PMID: 910135.
45. Haley BJ, Chen A, Grim CJ, et al. Vibrio cholerae in an Historically Cholera-Free Country. Environ Microbiol Rep. 2012 Aug 1;4(4):381-389. doi: 10.1111/j.1758-2229.2012.00332.x. PMID: 23185212; PMCID: PMC3505037.
46. Lutz C, Erken M, Noorian P, Sun S, McDougald D. Environmental reservoirs and mechanisms of persistence of Vibrio cholerae. Front Microbiol. 2013 Dec 16;4:375. doi: 10.3389/fmicb.2013.00375. PMID: 24379807; PMCID: PMC3863721.
47. Colwell RR, Seidler RJ, Kaper J, et al. Occurrence of Vibrio cholerae serotype O1 in Maryland and Louisiana estuaries. Appl Environ Microbiol. 1981 Feb;41(2):555-8. doi: 10.1128/aem.41.2.555-558.1981. PMID: 7235699; PMCID: PMC243732.
48. Dickinson G, Lim KY, Jiang SC. Quantitative microbial risk assessment of pathogenic vibrios in marine recreational waters of southern california. Appl Environ Microbiol. 2013 Jan;79(1):294-302. doi: 10.1128/AEM.02674-12. PMID: 23104412; PMCID: PMC3536113.
49. Hill VR, Cohen N, Kahler AM, et al. Toxigenic Vibrio cholerae O1 in water and seafood, Haiti. Emerg Infect Dis. 2011 Nov;17(11):2147-50. doi: 10.3201/eid1711.110748. PMID: 22099121; PMCID: PMC3310574.
50. Blackwell KD, Oliver JD. The ecology of Vibrio vulnificus, Vibrio cholerae, and Vibrio parahaemolyticus in North Carolina estuaries. J Microbiol. 2008 Apr;46(2):146-53. doi: 10.1007/s12275-007-0216-2. PMID: 18545963.
51. Franco AA, Fix AD, Prada A, et al. Cholera in Lima, Peru, correlates with prior isolation of Vibrio cholerae from the environment. Am J Epidemiol. 1997 Dec 15;146(12):1067-75. doi: 10.1093/oxfordjournals.aje.a009235. PMID: 9420531.
52. Sá LL, Vale ER, Garza DR, Vicente AC. Vibrio cholerae O1 from superficial water of the Tucunduba Stream, Brazilian Amazon. Braz J Microbiol. 2012 Apr;43(2):635-8. doi: 10.1590/S1517-83822012000200027. PMID: 24031874; PMCID: PMC3768806.
53. Taviani E, Ceccarelli D, Lazaro N, et al. Environmental Vibrio spp., isolated in Mozambique, contain a polymorphic group of integrative conjugative elements and class 1 integrons. FEMS Microbiol Ecol. 2008 Apr;64(1):45-54. doi: 10.1111/j.1574-6941.2008.00455.x. PMID: 18318712.
54. Mengel MA, Delrieu I, Heyerdahl L, Gessner BD. Cholera outbreaks in Africa. Curr Top Microbiol Immunol. 2014;379:117-44. doi: 10.1007/82_2014_369. PMID: 24827501.
55. Islam MS, Hasan MK, Miah MA, et al. Isolation of Vibrio cholerae O139 synonym Bengal from the aquatic environment in Bangladesh: implications for disease transmission. Appl Environ Microbiol. 1994 May;60(5):1684-6. doi: 10.1128/aem.60.5.1684-1686.1994. PMID: 8017948; PMCID: PMC201539.
56. Singh R, Narayan V, McLenachan P, et al. Detection and diversity of pathogenic Vibrio from Fiji. Environ Microbiol Rep. 2012 Aug;4(4):403-11. doi: 10.1111/j.1758-2229.2012.00344.x. PMID: 23760825.
57. Desmarchelier PM, Wong FY, Mallard K. An epidemiological study of Vibrio cholerae O1 in the Australian environment based on rRNA gene polymorphisms. Epidemiol Infect. 1995 Dec;115(3):435-46. doi: 10.1017/s0950268800058593. PMID: 8557075; PMCID: PMC2271589.
58. Miyagi K, Nakano T, Yagi T, et al. Survey of Vibrio cholerae O1 and its survival over the winter in marine water of Port of Osaka. Epidemiol Infect. 2003 Aug;131(1):613-9. doi: 10.1017/s0950268803008756. PMID: 12948359; PMCID: PMC2870000.
59. Bakhshi B, Barzelighi HM, Adabi M, Lari AR, Pourshafie MR. A molecular survey on virulence associated genotypes of non-O1 non-O139 Vibrio cholerae in aquatic environment of Tehran, Iran. Water Res. 2009 Mar;43(5):1441-7. doi: 10.1016/j.watres.2008.12.025. PMID: 19157484.
60. Rashid A, Haley BJ, Rajabov M, et al. Detection of Vibrio cholerae in environmental waters including drinking water reservoirs of Azerbaijan. Environ Microbiol Rep. 2013 Feb;5(1):30-8. doi: 10.1111/j.1758-2229.2012.00369.x. PMID: 23757128.
61. Grim CJ, Jaiani E, Whitehouse CA, et al. Detection of toxigenic Vibrio cholerae O1 in freshwater lakes of the former Soviet Republic of Georgia. Environ Microbiol Rep. 2010 Feb;2(1):2-6. doi: 10.1111/j.1758-2229.2009.00073.x. PMID: 23765992.
62. Andersson Y, Ekdahl K. Wound infections due to Vibrio cholerae in Sweden after swimming in the Baltic Sea, summer 2006. Euro Surveill. 2006 Aug 3;11(8):E060803.2. doi: 10.2807/esw.11.31.03013-en. PMID: 16966771.
63. Covazzi Harriague A, Brino MD, Zampini M, et al. Vibrios in association with sedimentary crustaceans in three beaches of the northern Adriatic Sea (Italy). Mar Pollut Bull. 2008 Mar;56(3):574-9. doi: 10.1016/j.marpolbul.2007.12.011. PMID: 18243247.
64. Kirschner AK, Schlesinger J, Farnleitner AH, et al. Rapid growth of planktonic Vibrio cholerae non-O1/non-O139 strains in a large alkaline lake in Austria: dependence on temperature and dissolved organic carbon quality. Appl Environ Microbiol. 2008 Apr;74(7):2004-15. doi: 10.1128/AEM.01739-07. PMID: 18245230; PMCID: PMC2292586.
65. Böer SI, Heinemeyer EA, Luden K, et al. Temporal and spatial distribution patterns of potentially pathogenic Vibrio spp. at recreational beaches of the German north sea. Microb Ecol. 2013 May;65(4):1052-67. doi: 10.1007/s00248-013-0221-4. PMID: 23563708.
66. Baker-Austin C, Trinanes JA, Salmenlinna S, et al. Heat Wave-Associated Vibriosis, Sweden and Finland, 2014. Emerg Infect Dis. 2016 Jul;22(7):1216-20. doi: 10.3201/eid2207.151996. PMID: 27314874; PMCID: PMC4918148.
67. McLaughlin JB, DePaola A, Bopp CA, et al. Outbreak of Vibrio parahaemolyticus gastroenteritis associated with Alaskan oysters. N Engl J Med. 2005 Oct 6;353(14):1463-70. doi: 10.1056/NEJMoa051594. PMID: 16207848.
68. Martinez-Urtaza J, Baker-Austin C, Jones JL, et al. Spread of Pacific Northwest Vibrio parahaemolyticus strain. N Engl J Med. 2013 Oct 17;369(16):1573-4. doi: 10.1056/NEJMc1305535. PMID: 24131194; PMCID: PMC4616000.
69. Vezzulli L, Brettar I, Pezzati E, et al. Long-term effects of ocean warming on the prokaryotic community: evidence from the vibrios. ISME J. 2012 Jan;6(1):21-30. doi: 10.1038/ismej.2011.89. PMID: 21753799; PMCID: PMC3246245.
70. Halpern BS, Walbridge S, Selkoe KA, et al. A global map of human impact on marine ecosystems. Science. 2008 Feb 15;319(5865):948-52. doi: 10.1126/science.1149345. PMID: 18276889.
71. Trinanes J, Martinez-Urtaza J. Future scenarios of risk of Vibrio infections in a warming planet: a global mapping study. Lancet Planet Health. 2021 Jul;5(7):e426-e435. doi: 10.1016/S2542-5196(21)00169-8. PMID: 34245713.
72. Chen YT, Tang HJ, Chao CM, Lai CC. Clinical manifestations of non-O1 Vibrio cholerae infections. PLoS One. 2015 Jan 20;10(1):e0116904. doi: 10.1371/journal.pone.0116904. PMID: 25602257; PMCID: PMC4300187.
73. Li M, Shimada T, Morris JG Jr, Sulakvelidze A, Sozhamannan S. Evidence for the emergence of non-O1 and non-O139 Vibrio cholerae strains with pathogenic potential by exchange of O-antigen biosynthesis regions. Infect Immun. 2002 May;70(5):2441-53. doi: 10.1128/IAI.70.5.2441-2453.2002. Erratum in: Infect Immun 2003 Jan;71(1):588. PMID: 11953381; PMCID: PMC127942.
74. Arita M, Takeda T, Honda T, Miwatani T. Purification and characterization of Vibrio cholerae non-O1 heat-stable enterotoxin. Infect Immun. 1986 Apr;52(1):45-9. doi: 10.1128/iai.52.1.45-49.1986. PMID: 3957432; PMCID: PMC262195.
75. Fernández-Ruiz M, Carretero O, Orellana MÁ. Bacteremia due to non-toxigenic Vibrio cholerae: The risks of eating seafood in a cirrhotic patient. Gastroenterol Hepatol. 2017 May;40(5):358-360. English, Spanish. doi: 10.1016/j.gastrohep.2016.04.010. PMID: 27242157.
76. Safrin S, Morris JG Jr, Adams M, et al. Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis. 1988 Sep-Oct;10(5):1012-7. doi: 10.1093/clinids/10.5.1012. PMID: 3055182.
77. Lin CJ, Chiu CT, Lin DY, Sheen IS, Lien JM. Non-O1 Vibrio cholerae bacteremia in patients with cirrhosis: 5-yr experience from a single medical center. Am J Gastroenterol. 1996 Feb;91(2):336-40. PMID: 8607503.
78. Rimola A, García-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000 Jan;32(1):142-53. doi: 10.1016/s0168-8278(00)80201-9. PMID: 10673079.
79. Andersen BR. Host factors causing increased susceptibility to infection in patients with Laennec's cirrhosis. Ann N Y Acad Sci. 1975 Apr 25;252:348-52. doi: 10.1111/j.1749-6632.1975.tb19178.x. PMID: 1096715.
80. Baumann M, Witzke O, Canbay A, et al. Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis. Hepatogastroenterology. 2004 Sep-Oct;51(59):1451-3. PMID: 15362774.
81. Ismail EA, Shafik MH, Al-Mutairi G. A case of non-O:1 Vibrio cholerae septicemia with meningitis, cerebral abscess and unilateral hydrocephalus in a preterm baby. Eur J Clin Microbiol Infect Dis. 2001 Aug;20(8):598-600. doi: 10.1007/s100960100553. PMID: 11681447.
82. Hao Y, Wang Y, Bi Z, et al. A case of non-O1/non-O139 Vibrio cholerae septicemia and meningitis in a neonate. Int J Infect Dis. 2015 Jun;35:117-9. doi: 10.1016/j.ijid.2015.05.004. PMID: 25975654.
83. Hirk S, Huhulescu S, Allerberger F, et al. Necrotizing fasciitis due to Vibrio cholerae non-O1/non-O139 after exposure to Austrian bathing sites. Wien Klin Wochenschr. 2016 Feb;128(3-4):141-5. doi: 10.1007/s00508-015-0944-y. PMID: 26825075; PMCID: PMC4771811.
84. Ottaviani D, Leoni F, Rocchegiani E, et al. Unusual case of necrotizing fasciitis caused by Vibrio cholerae O137. J Clin Microbiol. 2011 Feb;49(2):757-9. doi: 10.1128/JCM.02257-10. PMID: 21159937; PMCID: PMC3043468.
85. Ko WC, Chuang YC, Huang GC, Hsu SY. Infections due to non-O1 Vibrio cholerae in southern Taiwan: predominance in cirrhotic patients. Clin Infect Dis. 1998 Oct;27(4):774-80. doi: 10.1086/514947. PMID: 9798033.
86. Wagner PD, Evans SD, Dunlap J, Ballon-Landa G. Necrotizing fasciitis and septic shock caused by Vibrio cholerae acquired in San Diego, California. West J Med. 1995 Oct;163(4):375-7. PMID: 7483603; PMCID: PMC1303142.
87. Yang CC, Lee BJ, Yang SS, Lin YH, Lee YL. A case of non-O1 and non-O139 Vibrio cholerae septicemia with endophthalmitis in a cirrhotic patient. Jpn J Infect Dis. 2008 Nov;61(6):475-6. PMID: 19050358.
88. Wu Z, Nybom P, Magnusson KE. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol. 2000 Feb;2(1):11-7. doi: 10.1046/j.1462-5822.2000.00025.x. PMID: 11207559.
89. Kechker P, Senderovich Y, Ken-Dror S, et al. Otitis Media Caused by V. cholerae O100: A Case Report and Review of the Literature. Front Microbiol. 2017 Aug 28;8:1619. doi: 10.3389/fmicb.2017.01619. PMID: 28894440; PMCID: PMC5581382.
90. Dalsgaard A, Forslund A, Hesselbjerg A, Bruun B. Clinical manifestations and characterization of extra-intestinal Vibrio cholerae non-O1, non-O139 infections in Denmark. Clin Microbiol Infect. 2000 Nov;6(11):625-7. doi: 10.1046/j.1469-0691.2000.00174.x. PMID: 11168070.
91. Beneson AS, Islam MR, Greenough WB 3rd. Rapid identification of Vibrio cholerae by darkfield microscopy . Bull World Health Organ. 1964;30(6):827-31. PMID: 14215188; PMCID: PMC2555074.
92. Hoshino K, Yamasaki S, Mukhopadhyay AK, et al. Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Med Microbiol. 1998 Mar;20(3):201-7. doi: 10.1111/j.1574-695X.1998.tb01128.x. PMID: 9566491.
93. Khuntia HK, Pal BB, Chhotray GP. Quadruplex PCR for simultaneous detection of serotype, biotype, toxigenic potential, and central regulating factor of Vibrio cholerae. J Clin Microbiol. 2008 Jul;46(7):2399-401. doi: 10.1128/JCM.00024-08. PMID: 18463208; PMCID: PMC2446892.
94. Lotz MJ, Tamplin ML, Rodrick GE. Thiosulfate-citrate-bile salts-sucrose agar and its selectivity for clinical and marine vibrio organisms. Ann Clin Lab Sci. 1983 Jan-Feb;13(1):45-8. PMID: 6838150.
95. Ali A, Morris JG Jr, Johnson JA. Sugars inhibit expression of the rugose phenotype of Vibrio cholerae. J Clin Microbiol. 2005 Mar;43(3):1426-9. doi: 10.1128/JCM.43.3.1426-1429.2005. PMID: 15750123; PMCID: PMC1081252.
96. Yildiz FH, Schoolnik GK. Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4028-33. doi: 10.1073/pnas.96.7.4028. PMID: 10097157; PMCID: PMC22414.
97. O'Hara CM, Sowers EG, Bopp CA, Duda SB, Strockbine NA. Accuracy of six commercially available systems for identification of members of the family vibrionaceae. J Clin Microbiol. 2003 Dec;41(12):5654-9. doi: 10.1128/JCM.41.12.5654-5659.2003. PMID: 14662957; PMCID: PMC309021.
98. Moreno C, Romero J, Espejo RT. Polymorphism in repeated 16S rRNA genes is a common property of type strains and environmental isolates of the genus Vibrio. Microbiology (Reading). 2002 Apr;148(Pt 4):1233-1239. doi: 10.1099/00221287-148-4-1233. PMID: 11932467.
99. Tarr CL, Patel JS, Puhr ND, et al. Identification of Vibrio isolates by a multiplex PCR assay and rpoB sequence determination. J Clin Microbiol. 2007 Jan;45(1):134-40. doi: 10.1128/JCM.01544-06. PMID: 17093013; PMCID: PMC1828960.
100. Thompson FL, Gevers D, Thompson CC, et al. Phylogeny and molecular identification of vibrios on the basis of multilocus sequence analysis. Appl Environ Microbiol. 2005 Sep;71(9):5107-15. doi: 10.1128/AEM.71.9.5107-5115.2005. PMID: 16151093; PMCID: PMC1214639.
101. Dieckmann R, Strauch E, Alter T. Rapid identification and characterization of Vibrio species using whole-cell MALDI-TOF mass spectrometry. J Appl Microbiol. 2010 Jul;109(1):199-211. doi: 10.1111/j.1365-2672.2009.04647.x. PMID: 20059616.
102. Manji R, Bythrow M, Branda JA, et al. Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):337-46. doi: 10.1007/s10096-013-1961-2. PMID: 24019163.
103. Kam KM, Luey CK, Parsons MB, et al. Evaluation and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping Vibrio parahaemolyticus: an international multicenter collaborative study. J Clin Microbiol. 2008 Aug;46(8):2766-73. doi: 10.1128/JCM.00424-08. PMID: 18579720; PMCID: PMC2519496.
104. Frerichs RR, Keim PS, Barrais R, Piarroux R. Nepalese origin of cholera epidemic in Haiti. Clin Microbiol Infect. 2012 Jun;18(6):E158-63. doi: 10.1111/j.1469-0691.2012.03841.x. PMID: 22510219.
105. Katz LS, Petkau A, Beaulaurier J, et al. Evolutionary dynamics of Vibrio cholerae O1 following a single-source introduction to Haiti. mBio. 2013 Jul 2;4(4):e00398-13. doi: 10.1128/mBio.00398-13. PMID: 23820394; PMCID: PMC3705451.
106. Laviad-Shitrit S, Sharaby Y, Izhaki I, Peretz A, Halpern M. Antimicrobial Susceptibility of Environmental Non-O1/Non-O139 Vibrio cholerae Isolates. Front Microbiol. 2018 Aug 2;9:1726. doi: 10.3389/fmicb.2018.01726. PMID: 30116229; PMCID: PMC6083052.
107. Rodríguez JY, Duarte C, Rodríguez GJ, et al. Bacteremia by non-O1/non-O139 Vibrio cholerae: Case description and literature review. Biomedica. 2023 Sep 30;43(3):323-329. doi: 10.7705/biomedica.6716. PMID: 37871571; PMCID: PMC10615443.
108. Das B, Verma J, Kumar P, Ghosh A, Ramamurthy T. Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanisms. Vaccine. 2020 Feb 29;38 Suppl 1:A83-A92. doi: 10.1016/j.vaccine.2019.06.031. Epub 2019 Jul 2. PMID: 31272870.
109. Chowdhury G, Joshi S, Bhattacharya S, et al. Extraintestinal Infections Caused by Non-toxigenic Vibrio cholerae non-O1/non-O139. Front Microbiol. 2016 Feb 11;7:144. doi: 10.3389/fmicb.2016.00144. PMID: 26904017; PMCID: PMC4749697.
110. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52. doi: 10.1093/cid/ciu444. Erratum in: Clin Infect Dis. 2015 May 1;60(9):1448. doi: 10.1093/cid/civ114. Dosage error in article text. PMID: 24973422.
111. Chen SC, Lee YT, Tsai SJ, et al. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period. J Antimicrob Chemother. 2012 Feb;67(2):488-93. doi: 10.1093/jac/dkr476. PMID: 22117030.
112. Kim SE, Kim HK, Choi SM, et al. In Vitro Synergy and In Vivo Activity of Tigecycline-Ciprofloxacin Combination Therapy against Vibrio vulnificus Sepsis. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00310-19. doi: 10.1128/AAC.00310-19. PMID: 31332060; PMCID: PMC6761547.
113. Hwang S, Kim Y, Jung H, et al. A Fatal Case of Bacteremia Caused by Vibrio cholerae Non-O1/O139. Infect Chemother. 2021 Jun;53(2):384-390. doi: 10.3947/ic.2020.0301. PMID: 32869555; PMCID: PMC8258294.
114. Vezzulli L. Global expansion of Vibrio spp. in hot water. Environ Microbiol Rep. 2023 Apr;15(2):77-79. doi: 10.1111/1758-2229.13135. PMID: 36519781; PMCID: PMC10103853.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.